Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 1;10(suppl_1):i40-i48.
doi: 10.1093/inthealth/ihx054.

Alternative treatment strategies to accelerate the elimination of onchocerciasis

Michel Boussinesq  1 , Grace Fobi  2 , Annette C Kuesel  3
Affiliations

Alternative treatment strategies to accelerate the elimination of onchocerciasis

Michel Boussinesq et al. Int Health. .

Abstract

The use of alternative (or complementary) treatment strategies (ATSs) i.e. differing from annual community-directed treatment with ivermectin (CDTI) is required in some African foci to eliminate onchocerciasis by 2025. ATSs include vector control, biannual or pluriannual CDTI, better timing of CDTI, community-directed treatment with combinations of currently available anthelminthics or new drugs, and 'test-and-treat' (TNT) strategies requiring diagnosis of infection and/or contraindications to treatment for decisions on who to treat with what regimen. Two TNT strategies can be considered. Loa-first TNT, designed for loiasis-endemic areas and currently being evaluated using a rapid test (LoaScope), consists of identifying individuals with levels of Loa microfilaremia associated with a risk of post-ivermectin severe adverse events to exclude them from ivermectin treatment and in treating the rest (usually >97%) of the population safely. Oncho-first TNT consists of testing community members for onchocerciasis before giving treatment (currently ivermectin or doxycycline) to those who are infected. The choice of the ATS depends on the prevalences and intensities of infection with Onchocerca volvulus and Loa loa and on the relative cost-effectiveness of the strategies for the given epidemiological situation. Modelling can help select the optimal strategies, but field evaluations to determine the relative cost-effectiveness are urgently needed.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Decision trees for tests and treatment within the two possible TNT strategies: (a) Loa-first TNT; (b) Oncho-first TNT. The sizes of the circles correspond to the approximate relative size of the population to be tested or treated at each step in a community where loiasis coexists with hypoendemic onchocerciasis.
Figure 2.
Figure 2.
(a) Distribution of the individuals in a community where loiasis coexists with hypoendemic onchocerciasis according to their status regarding onchocerciasis (active infection or not) and their risk of developing a post-ivermectin SAE (individuals with >30,000 Loa mf/mL). (b) Treatment given (or not) to subjects in each of the four categories by TNT strategy used (Loa-first vs Oncho-first).
See this image and copyright information in PMC

References

    1. Sauerbrey M. The Onchocerciasis Elimination Program for the Americas (OEPA). Ann Trop Med Parasitol 2008;102(Suppl 1):25–9. - PubMed
    1. Botto C, Basanez MG, Escalona M et al. Evidence of suppression of onchocerciasis transmission in the Venezuelan Amazonian focus. Parasit Vectors 2016;9:40. - PMC - PubMed
    1. Rodriguez-Perez MA, Fernandez-Santos NA, Orozco-Algarra ME et al. Elimination of onchocerciasis from Mexico. PLoS Negl Trop Dis 2015;9(7):e0003922. - PMC - PubMed
    1. Progress toward eliminating onchocerciasis in the WHO Region of the Americas: verification of elimination of transmission in Mexico. Wkly Epidemiol Rec 2015;90(43):577–81. - PubMed
    1. Boatin B. The Onchocerciasis Control Programme in West Africa (OCP). Ann Trop Med Parasitol 2008;102(Suppl 1):13–7. - PubMed

MeSH terms

LinkOut - more resources